Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells

by Bo Han, Hyeon‐Cheol Lee‐Okada, Momoko Ishimine, Hajime Orita, Keiko Nishikawa, Tetsuya Takagaki, Kazunori Kajino, Takehiko Yokomizo, Okio Hino, Toshiyuki Kobayashi
Published 2020-11-01